FluoroPharma Medical, Inc. (FPMI) Announces Appointment Of Lawrence Atinsky To Board Of Directors
FluoroPharma Medical, a biopharmaceutical company providing proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels, announced today that it has appointed Lawrence Atinsky to its Board of Directors. The appointment is effective January 3, 2012. Mr. Atinsky has worked closely with a number of biotechnology companies over the past ten years, helping them execute their strategic growth plans, and is currently a partner at Ascent Biomedical Ventures. Ascent is a venture capital firm targeting early stage biomedical technology companies developing medical devices, biopharmaceuticals, healthcare services, and information technology. Prior to joining Ascent, Mr. Atinsky was…